Skip to main content
. 2018 Sep 24;8:14299. doi: 10.1038/s41598-018-32653-2

Figure 4.

Figure 4

Characterization of D2.0R dissemination to bone. (a) Representative hematoxylin and eosin (H&E) images of D2.0R-inoculated tibiae from −E2 (n = 8 mice) and +E2 (n = 6 mice) mice. Left panels = 4X, right panels = 20X of same tibiae. Scale bars = 500 μM (left panel) and 100 μM (right panel). (b) Histomorphometric analysis of bone volume/total volume (%BV/TV) from mice described in (a) and non-tumor-inoculated (naïve) mice (n = 10 −E2 mice, n = 8 +E2 mice). (c) Representative microCT images of mice described in (a) and (b). (d) microCT analysis of mice described in (c). (e) qPCR analysis of whole bone homogenates from non-tumor-inoculated mice and D2.0R-inoculated mice described in (a) and (b) for Krt18, normalized to mouse B2m. (f) Positive pan-cytokeratin (AE1/AE3) staining in the tibia from a D2.0R-inoculated mouse (mouse number 5). Arrows indicate cytokeratin-positive tumor cells. Left panel = 4X, right panel = 40X of the same tibia. Scale bars = 500 μM (left panel) and 100 μM (right panel). (b,d,e) One-way ANOVA with Sidak’s multiple comparisons test, *P < 0.05, ***P < 0.001 and ****P < 0.0001.